- Bone
marrow suppression also
known as
myelotoxicity or
myelosuppression, is the
decrease in
production of
cells responsible for
providing immunity (leukocytes)...
-
myelosuppression. ++
means 30-70% of
patients exhibit significant myelosuppression. +
means 10-30% of
patients exhibit significant myelosuppression....
- follicles. This
results in the most
common side-effects of chemotherapy:
myelosuppression (decreased
production of
blood cells,
hence that also immunosuppression)...
-
lymphocyte proliferation via
conversion to
mercaptopurine PO, IV D (Au)
Myelosuppression and
rarely malignancy, hepatitis, infection,
hepatic sinusoidal obstruction...
- Hair loss
Dermatitis Indigestion Shortness of
breath Eye
irritation Myelosuppression Notes on
adverse effects: Includes: anaemia, lymphopenia, neutropenia...
- part of SCLC
treatment frequently experience chemotherapy-induced
myelosuppression. In
three randomized, placebo-controlled SCLC trials, trilaciclib,...
-
Myelodysplastic syndromes,
acute myeloid leukaemia and
chronic myeloid leukaemia Myelosuppression,
kidney failure (uncommon/rare),
renal tubular acidosis and hypokalaemia...
-
Diarrhea (see
below for details)
Mucositis Headache Hand-foot
syndrome Myelosuppression (see
below for details)
Alopecia (hair loss)
Photosensitivity Maculopa****r...
- the bile and intestines. It can
cause the
symptoms of
diarrhoea and
myelosuppression experienced by ~25% of the
patients administered irinotecan. Click...
-
sometimes as low as 10% of its
usual production levels. The
nadir of this
myelosuppression usually occurs 21–28 days
after the
first treatment,
after which the...
